Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of the therapy combining GA and NAC on disease activity as
reflected by MRI parameters while assessing tolerability and safety.
Phase:
Phase 2
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc. Teva Pharmaceutical Industries